| Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlations I Zerdes, A Matikas, J Bergh, GZ Rassidakis, T Foukakis Oncogene 37 (34), 4639-4661, 2018 | 255 | 2018 |
| Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of … H Polioudaki, S Agelaki, R Chiotaki, E Politaki, D Mavroudis, A Matikas, ... BMC cancer 15, 1-10, 2015 | 153 | 2015 |
| Targeting KRAS mutated non-small cell lung cancer: A history of failures and a future of hope for a diverse entity A Matikas, D Mistriotis, V Georgoulias, A Kotsakis Critical reviews in oncology/hematology 110, 1-12, 2017 | 99 | 2017 |
| Prognostic implications of PD-L1 expression in breast cancer: systematic review and meta-analysis of immunohistochemistry and pooled analysis of transcriptomic data A Matikas, I Zerdes, J Lövrot, F Richard, C Sotiriou, J Bergh, A Valachis, ... Clinical Cancer Research 25 (18), 5717-5726, 2019 | 92 | 2019 |
| Beyond PD-1/PD-L1 inhibition: what the future holds for breast cancer immunotherapy S Chrétien, I Zerdes, J Bergh, A Matikas, T Foukakis Cancers 11 (5), 628, 2019 | 63 | 2019 |
| Circulating biomarkers in non–small-cell lung cancer: current status and future challenges A Matikas, KN Syrigos, S Agelaki Clinical lung cancer 17 (6), 507-516, 2016 | 59 | 2016 |
| Discordance of PD-L1 status between primary and metastatic breast cancer: A systematic review and meta-analysis C Boman, I Zerdes, K Mårtensson, J Bergh, T Foukakis, A Valachis, ... Cancer Treatment Reviews 99, 102257, 2021 | 55 | 2021 |
| Targeting angiogenesis in small cell lung cancer M Stratigos, A Matikas, A Voutsina, D Mavroudis, V Georgoulias Translational lung cancer research 5 (4), 389, 2016 | 47 | 2016 |
| Immune gene expression and response to chemotherapy in advanced breast cancer T Foukakis, J Lövrot, A Matikas, I Zerdes, J Lorent, N Tobin, C Suzuki, ... British journal of cancer 118 (4), 480-488, 2018 | 43 | 2018 |
| Current and future approaches in the management of non–small-cell lung cancer patients with resistance to EGFR TKIs A Matikas, D Mistriotis, V Georgoulias, A Kotsakis Clinical lung cancer 16 (4), 252-261, 2015 | 43 | 2015 |
| Avoiding over-and undertreatment in patients with resected node-positive breast cancer with the use of gene expression signatures: are we there yet? A Matikas, T Foukakis, S Swain, J Bergh Annals of Oncology 30 (7), 1044-1050, 2019 | 40 | 2019 |
| G-CSF-induced aortitis: two cases and review of the literature I Parodis, L Dani, A Notarnicola, G Martenhed, P Fernström, A Matikas, ... Autoimmunity Reviews 18 (6), 615-620, 2019 | 36 | 2019 |
| Expression of truncated human epidermal growth factor receptor 2 on circulating tumor cells of breast cancer patients G Kallergi, S Agelaki, MA Papadaki, D Nasias, A Matikas, D Mavroudis, ... Breast Cancer Research 17, 1-11, 2015 | 29 | 2015 |
| Dose-dense FEC followed by docetaxel versus docetaxel plus cyclophosphamide as adjuvant chemotherapy in women with HER2-negative, axillary lymph node-positive early breast … D Mavroudis, A Matikas, N Malamos, P Papakotoulas, S Kakolyris, ... Annals of Oncology 27 (10), 1873-1878, 2016 | 27 | 2016 |
| A multicentre phase II trial of cabazitaxel in patients with advanced non-small-cell lung cancer progressing after docetaxel-based chemotherapy A Kotsakis, A Matikas, F Koinis, N Kentepozidis, II Varthalitis, ... British journal of cancer 115 (7), 784-788, 2016 | 26 | 2016 |
| Management of Resistance to Crizotinib in Anaplastic Lymphoma Kinase-Positive Non–Small-cell Lung Cancer A Matikas, N Kentepozidis, V Georgoulias, A Kotsakis Clinical Lung Cancer 17 (6), 474-482, 2016 | 23 | 2016 |
| Programmed death‐ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21‐gene and 70‐gene signatures in estrogen … I Zerdes, EG Sifakis, A Matikas, S Chrétien, NP Tobin, J Hartman, ... Molecular oncology 14 (5), 951-963, 2020 | 22 | 2020 |
| Primary bone lymphoma: a retrospective analysis of 22 patients treated in a single tertiary center A Matikas, A Briasoulis, I Tzannou, D Oikonomopoulou, M Bakiri, ... Acta Haematologica 130 (4), 291-296, 2013 | 22 | 2013 |
| Detection of circulating tumour cells before and following adjuvant chemotherapy and long-term prognosis of early breast cancer A Matikas, A Kotsakis, S Apostolaki, H Politaki, M Perraki, K Kalbakis, ... British Journal of Cancer 126 (11), 1563-1569, 2022 | 21 | 2022 |
| Dynamic evaluation of the immune infiltrate and immune function genes as predictive markers for neoadjuvant chemotherapy in hormone receptor positive, HER2 negative breast cancer A Matikas, J Lövrot, A Ramberg, M Eriksson, T Lindsten, T Lekberg, ... Oncoimmunology 7 (9), e1466017, 2018 | 21 | 2018 |
